Identification of Novel Prognostic Biomarkers for Colorectal Cancer by Bioinformatics Analysis
Turkish Journal of Gastroenterology · 02.01.2024 · 35 (1) · 61-72
DOI: 10.5152/tjg.2024.23264 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turkish Journal of Gastroenterology, online erschienen am 02.01.2024. Verfasst von Chao Niu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Affiliated Hospital of Yunnan University, Kunming, Yunnan Province, China. Hauptthemen laut MEDLINE: Protein Interaction Maps, Colorectal Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background/Aims: Colorectal cancer (CRC) ranks third among malignancies in terms of global incidence and has a poor prognosis. The identification of effective diagnostic and prognostic biomarkers is critical for CRC treatment. This study intends to explore novel genes associated with CRC progression via bioinformatics analysis. Materials and Methods: Dataset GSE184093 was selected from the Gene Expression Omnibus database to identify differentially expressed genes (DEGs) between CRC and noncancerous specimens. Functional enrichment analyses were implemented for probing the biological functions of DEGs. Gene Expression Profiling Interactive Analysis and Kaplan–Meier plotter databases were employed for gene expression detection and survival analysis, respectively. Western blotting and real-time quantitative polymerase chain reaction were employed for detecting molecular protein and messenger RNA levels, respectively. Flow cytometry, Transwell, and CCK-8 assays were utilized for examining the effects of GBA2 and ST3GAL5 on CRC cell behaviors.
Results
There were 6464 DEGs identified, comprising 3005 downregulated DEGs (dDEGs) and 3459 upregulated DEGs (uDEGs). SixdDEGs were significantly associated with the prognoses of CRC patients, including PLCE1, PTGS1, AMT, ST8SIA1, ST3GAL5, and GBA2. Upregulating ST3GAL5 or GBA2 repressed the malignant behaviors of CRC cells.
Conclusion
We identified 6 genes related to CRC progression, which could improve the disease prognosis and treatment. Cite this article as: Niu C, Li X, Lei Luo X, et al. Identification of novel prognostic biomarkers for colorectal cancer by bioinformatics analysis. Turk J Gastroenterol. 2024;35(1):61-72.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, The Affiliated Hospital of Yunnan University, Kunming, Yunnan Province, China.
Zitieren
APA
Niu, C., Li, X., Lei Luo, X., Wan, H., Jin, W., Zhang, Z., Zhang, W., & Li, B. (2024). Identification of Novel Prognostic Biomarkers for Colorectal Cancer by Bioinformatics Analysis. Turkish Journal of Gastroenterology, 35(1), 61-72. https://doi.org/10.5152/tjg.2024.23264
Vancouver
Niu C, Li X, Lei Luo X, Wan H, Jin W, Zhang Z, et al. Identification of Novel Prognostic Biomarkers for Colorectal Cancer by Bioinformatics Analysis. Turkish Journal of Gastroenterology. 2024;35(1):61-72. doi:10.5152/tjg.2024.23264
BibTeX
@article{Niu2024,
author = {Niu, Chao and Li, Xiaogang and Lei Luo, Xian and Wan, Hongwei and Jin, Wendi and Zhang, Zhiping and Zhang, Wanfu and Li, Bo},
title = {Identification of Novel Prognostic Biomarkers for Colorectal Cancer by Bioinformatics Analysis},
journal = {Turkish Journal of Gastroenterology},
year = {2024},
volume = {35},
number = {1},
pages = {61--72},
doi = {10.5152/tjg.2024.23264}
}
EUVIMED